Clarian Health this decade has transformed its transplant program into one of the busiest in the country. Its team of surgeons
takes calls around the clock if a viable organ becomes available. They will hop on a charter plane to check out an organ other
doctors don’t want.
Around Indiana, hospitals continue to grow and add workers, increasing their role as an economic driver to the state’s economy.
But health care reformers say hospital growth has a double edge, as higher health care costs dampen growth prospects for other
Indiana employers and their workers.
Four years after its launch, the Indiana Health Information Exchange is laying the groundwork to take its game outside state
borders. The Indianapolis-based not-for-profit offers a service that provides patient records and test results via computer
to hospitals and doctors around central Indiana. But now, its leaders think they can take their expertise to other cities
and help them develop their own health information exchanges.
Economists call it a “virtuous cycle” when successful entrepreneurs plow their gains into new businesses. Jim Pearson calls
it another day on the job. The former Suros Surgical Systems Inc. CEO is attempting to repeat what he already has done: Build
a company to bring a promising medical device all the way from the drawing board to the market.
Service Employees International Union Local 3 is backing local janitors as they restart contract negotiations April 16 with
five of the largest janitorial contractors in Indianapolis. SEIU now is taking direct aim at Lilly, health insurer WellPoint
Inc. and even some local hospitals, hoping they will pressure the janitorial contractors to come to terms.
Anthem Insurance Co. added nearly 75,000 commercial customers last year, pushing its total up more than 4 percent. Anthem,
a subsidiary of Indianapolis-based WellPoint Inc., now claims a whopping 1.8 million commercial customers in the state. The
trouble is, Anthem’s dominance limits price competition, according to benefits brokers, making it hard for local HMOs such
as M-Plan or even some national players to compete.
The “father of health savings accounts” isn’t satisfied. At 80, J. Patrick Rooney is gearing up for another health care reform
battle in Washington–five years after winning a colossal victory when Congress awarded health savings accounts tax-free status.
Clarian Health has acquired a controlling stake in a cardiology practice based at the Indiana Heart Hospital, which is owned
by Clarian competitor Community Health Network.
Eli Lilly and Co. hopes to extend the life of its best-seller Zyprexa with a potentially lucrative, long-acting form of the antipsychotic drug. But first, the Indianapolis-based drugmaker must win over a panel of medical experts convened by the U.S. Food and Drug Administration on Feb. 6.
Three months after launching an initiative to boost drug-development firms in Indiana, officials at BioCrossroads have written
a report that attempts to show in detail the vast market opportunity they see.
At the beginning of 2007, few people outside WellPoint Inc. had even heard of Angela Braly. Nine months later, Fortune magazine
named her the fourth most powerful woman in business.
A new leader will guide the city’s largest company in 2008, with some of the biggest challenges in its history on the horizon.
Eli Lilly and Co. announced Dec. 18 that CEO Sidney Taurel will step down March 31 and will be replaced by President John
C. Lechleiter, who has been the heir apparent for more than two years.
John C. Lechleiter, whom Eli Lilly and Co.’s board voted to replace Sidney Taurel as CEO, is known for getting things done
and yet also for being good at analysis and relating to people under him. Taurel will step down at the end of March but remain
chairman until the end of 2008.
Eli Lilly and Co. will shrink itself with “great intensity” over the next few years, in part by
outsourcing. For other local life sciences firms, that’s a fat pitch for new business. But it’s not clear if non-Lilly firms
can grow fast enough to offset the jobs and wages Indianapolis will lose from Lilly.
Clarian Health officials say the only way they can keep operating their medical centers downtown is to support them with profitable
suburban hospitals. So far, it seems Clarian is on the right track. As Clarian moves forward with a new, $180 million hospital
in Fishers, its two existing suburban hospitals are starting to make money.
WellPoint, Indiana’s largest health insurer, is making more noise than ever about what it’s doing to help improve Hoosiers’
and Americans’ health.
There’s a $2 billion hole in Eli Lilly and Co.’s future. That’s roughly how much pretax profit Lilly derives each year from
its best-seller, Zyprexa, according to calculations by IBJ. And it’s how much black ink will start running off Lilly’s books
once Zyprexa’s U.S. and European patents expire in 2011.
WellPoint Inc. and Angie’s List are both racing to launch doctor-rating services early next year. But Angie’s List is already
sour over Well-Point’s decision to partner with New York-based Zagat Survey LLC for its doctor-rating service, apparently
without talking to Angie’s List.
Fifteen senior executives have left WellPoint Inc. since November 2004, when the giant health insurer formed through Indianapolis-based
Anthem Inc.’s $16.5 billion acquisition of California-based WellPoint Health Networks Inc. The merger made many of them rich,
work at WellPoint was grueling, and personal commitments called. So they moved on.
Spending on health care is rising faster in Indiana than it is across the country. Yet the state’s job and income growth continue
to lag national norms.
